Escitalopram in the treatment of depressed elderly patients

American Journal of Geriatric Psychiatry

Volumn 13, Issue 10, 2005, Pages 884-891

  Kasper, Siegfried ^a   De Swart, Hans ^b   Andersen, Henning Friis ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; FLUOXETINE; PLACEBO; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL PAIN; ACCIDENTAL INJURY; AGED; ANOREXIA; ANXIETY DISORDER; ARTICLE; BACKACHE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ELDERLY CARE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HYPERTENSION; HYPONATREMIA; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; ORTHOSTATIC HYPOTENSION; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; VERTIGO; XEROSTOMIA;

AGED; AGED, 80 AND OVER; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS;

EID: 33644875034     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/00019442-200510000-00008     Document Type: Article

References (31)

1. Gildengers AG, Houck PR, Mulsant BH, et al: Course and rate of antidepressant response in the very old. J Affect Disord 2002; 69:177-184
2. Sonnenberg CM, Beekman AT, Deeg DJ, et al: Drug treatment in depressed elderly in the Dutch community. Int J Geriatr Psychiatry 2003; 18:99-104
3. Kehoe WA: Factors affecting the use and selection of antidepressants in the elderly. Experimental Review of Neurotherapeutics 2002; 2:35-43
4. Mathews M, Mathews M, Mathews J: Recognition and treatment of depression in the elderly. Primary Psychiatry 2004; 11:33-37
5. Van den Berg MD, Oldehinkel AJ, Bouhuys AL, et al: Depression in later life: three etiologically different subgroups. J Affect Disord 2001; 65:19-26
6. Hall WD, Mant A, Mitchell PB, et al: Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ 2003; 326:1008-1012
7. Crome P, Ford G: Drugs and the Older Population. London, UK, Imperial College Press, 2000
8. Owens MJ, Knight DL, Nemeroff CB: Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 2001; 50:345-350
9. Burke WJ, Gergel I, Bose A: Fixed-dose trial of the single-isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002; 63:331-336
10. Wade A, Lemming MO, Hedegaard KB: Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2002; 17:95-102
11. Lepola UM, Loft H, Reines EH: Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003; 18:211-217
12. von Moltke LL, Greenblatt DJ, Giancarlo GM, et al: Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. Drug Metab Dispos 2001; 29:1102-1109
13. Tollefson GD, Bosomworth JC, Heligenstein JH, et al: A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression: The Fluoxetine Collaborative Study Group. Int Psychogeriatr 1995; 7:89-104
14. Evans M, Hammond M, Wilson K, et al: Placebo-controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry 1997; 12:817-824
15. Schatzberg AF, Cantillon M: Antidepressant early response and remission of venlafaxine and fluoxetine in geriatric outpatients. Eur Neuropsychopharmacol 2002; 10(suppl3):S225-S226
16. Walsh BT, Seidman SN, Sysko R, et al: Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002; 287:1840-1847
17. Solai LK, Mulsant BH, Pollock BG: Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs Aging 2001; 18:355-368
18. Kurzthaler I, Hotter A, Miller C, et al: Risk profile of SSRIs in elderly depressive patients with comorbid physical illness. Pharmacopsychiatry 2001; 34:114-118
19. Schneider LS, Nelson JC, Clary CM, et al: An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 2003; 160:1277-1285
20. Taylor WD, Doraiswamy PM: A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future. Neuropsychopharmacology 2004; 29:2285-2299
21. Roose SP, Sackeim HA, KBR Krishnaan, et al: Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 2004; 161:2050-2059
22. Klysner R, Bent-Hansen J, Hansen HL, et al: Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br J Psychiatry 2002; 181:29-35
23. Barak Y, Swartz M, Levy D, et al: Age-related differences in the side-effect profile of citalopram. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:545-548
24. Bruce ML, Ten Have TR, Reynolds CF III, et al: Reducing suicidal ideation and depressive symptoms in depressed older primary-care patients: a randomized, controlled trial. JAMA 2004; 291:1081-1091
25. Cassano GB, Puca F, Scapicchio PL, et al: Italian Study Group on Depression in Elderly Patients: Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. J Clin Psychiatry 2002; 63:396-402
26. Quitkin FM, Petkova E, McGrath PJ, et al: When should a trial of fluoxetine for major depression be declared failed? Am J Psychiatry 2003; 160:734-740
27. Thomas L, Mulsant BH, Solano FX, et al: Response speed and rate of remission in primary and specialty care of elderly patients with depression. Am J Geriatr Psychiatry 2002; 10:583-591
28. Newhouse PA, Krishnan KR, Doraiswamy PM, et al: A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry 2000; 61:559-568
29. Devanand DP, Nobler MS, Cheng J, et al: Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder. Am J Geriatr Psychiatry 2005; 13:59-68
30. Cassano P, Soares CN, Cohen LS, et al: Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine. Archives of Women's Mental Health 2004; 7:167-171
31. Wilson KC, Mottram PG, Ashworth L, et al: Older community residents with depression: long-term treatment with sertraline: randomised, double-blind, placebo-controlled study. Br J Psychiatry 2003; 182:492-497